NAS:ETON (USA)

Eton Pharmaceuticals Inc

$ 5.68 -0.03 (-0.53%)
Volume: 29,210 Avg Vol (1m): 70,491
Market Cap $: 100.89 Mil Enterprise Value $: 81.42 Mil
P/E (TTM): 0.00 P/B: 5.18
Earnings Power Value 0
Net Current Asset Value 1.01
Tangible Book 1.1
Projected FCF 0
Median P/S Value 7.79
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 7/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 164.57
Cash-To-Debt range over the past 10 years
Min: 164.57, Med: 10000, Max: 10000
Current: 164.57
164.57
10000
Equity-to-Asset 0.84
N/A
Debt-to-Equity 0.01
N/A
Debt-to-EBITDA -0.01
Debt-to-EBITDA range over the past 10 years
Min: -0.01, Med: 0, Max: 0
Current: -0.01
-0.01
0
Altman Z-Score 12.96
DISTRESS
GREY
SAFE

Profitability & Growth : 1/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -2982.20
Operating Margin range over the past 10 years
Min: -2982.2, Med: 0, Max: 0
Current: -2982.2
-2982.2
0
Net Margin % -3426.40
Net Margin range over the past 10 years
Min: -3426.4, Med: 0, Max: 0
Current: -3426.4
-3426.4
0
ROE % -728.05
ROE range over the past 10 years
Min: -728.05, Med: -383.23, Max: -383.23
Current: -728.05
-728.05
-383.23
ROA % -106.77
ROA range over the past 10 years
Min: -106.77, Med: -61, Max: -61
Current: -106.77
-106.77
-61
ROC (Joel Greenblatt) % -2554.13
ROC (Joel Greenblatt) range over the past 10 years
Min: -2554.13, Med: -2314.13, Max: -2314.13
Current: -2554.13
-2554.13
-2314.13

Ratios

Current vs industry vs history
PB Ratio 5.18
PB Ratio range over the past 10 years
Min: 4.96, Med: 7.09, Max: 7.59
Current: 5.18
4.96
7.59
PS Ratio 194.63
PS Ratio range over the past 10 years
Min: 185.72, Med: 268.62, Max: 287.59
Current: 194.63
185.72
287.59
EV-to-EBIT -5.42
EV-to-EBIT range over the past 10 years
Min: -8.5, Med: -7.8, Max: -5.11
Current: -5.42
-8.5
-5.11
EV-to-EBITDA -5.44
EV-to-EBITDA range over the past 10 years
Min: -8.5, Med: -7.9, Max: -5.13
Current: -5.44
-8.5
-5.13
EV-to-Revenue 160.14
EV-to-Revenue range over the past 10 years
Min: 180.2, Med: 233.8, Max: 253
Current: 160.14
180.2
253
Current Ratio 5.89
Current Ratio range over the past 10 years
Min: 5.68, Med: 8.08, Max: 13.59
Current: 5.89
5.68
13.59
Quick Ratio 5.89
Quick Ratio range over the past 10 years
Min: 5.68, Med: 8.08, Max: 13.59
Current: 5.89
5.68
13.59

Dividend & Buy Back

Current vs industry vs history

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 5.16
Price-to-Tangible-Book range over the past 10 years
Min: 4.1, Med: 5.69, Max: 7.28
Current: 5.16
4.1
7.28
Price-to-Median-PS-Value 0.73
Price-to-Median-PS-Value range over the past 10 years
Min: 0.7, Med: 1.03, Max: 1.03
Current: 0.73
0.7
1.03
Earnings Yield (Joel Greenblatt) % -18.67
Earnings Yield (Greenblatt) range over the past 10 years
Min: -19.81, Med: -12.8, Max: -11.8
Current: -18.67
-19.81
-11.8

» ETON's 30-Y Financials

Financials (Next Earnings Date: 2019-12-20)

» Interactive Chart

Peter Lynch Chart

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:ETON

Business Description

Industry Biotechnology » Biotechnology    NAICS : 325412    SIC : 2834
Compare
Traded in other countries
Address 21925 W. Field Parkway, Suite 235, Deer Park, IL, USA, 60010

More Statistics

Revenue (TTM) (Mil) $ 0.5
EPS (TTM) $ -2.66
Beta 0
Volatility % 0
52-Week Range $ 5.38 - 10.2
Shares Outstanding (Mil) 17.76

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 0
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA N
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N